As cancer treatment advances, patients and doctors push back against drugs' harsh side effects
Through Project Optimus, the US Food and Drug Administration is encouraging drug developers to conduct more head-to-head dosing comparisons.
Through RSS Feeds 
Through Project Optimus, the US Food and Drug Administration is encouraging drug developers to conduct more head-to-head dosing comparisons.
